Investigator
Changzhou University
Discovery of potent NAMPT-Targeting PROTACs using FK866 as the warhead
Nicotinamide phosphoribosyltransferase (NAMPT) has emerged as a promising target for cancer therapy due to its strong correlation with nicotinamide adenine dinucleotide (NAD
